Validez y confiabilidad de la escala del Center for Epidemiologic Studies-Depression en estudiantes adolescentes de Colombia
Palabras clave:
reproducibilidad de resultados, validez de las pruebas, trastorno depresivo mayor, psiquiatría del adolescente, escalas de valoración psiquiátrica, cribado
Resumen
Introducción. El trastorno depresivo mayor es la segunda causa productora de discapacidad en Latinoamérica. No hay escalas validadas en Colombia para adolescentes.Objetivo. Evaluar la validez y la confiabilidad de la escala del Centro de Estudios Epidemiológicos para la Depresión en adolescentes colombianos en edad escolar.
Materiales y métodos. Se llevó a cabo un estudio de validación de la escala con una muestra de adolescentes en edad escolar de Bucaramanga. Se evaluaron con la escala para depresión y la entrevista clínica estructurada. La escala fue aplicada nuevamente 3 a 28 días después. Se determinaron la validez de criterio, la consistencia interna y la reproducibilidad prueba reprueba.
Resultados. Se evaluaron 390 adolescentes con edad promedio de 14,8±1,22 años. La prevalencia de trastorno depresivo mayor fue de 11,5%. El índice de consistencia, o alfa de Cronbach, fue de 0,85. El área bajo la curva según las características receptor operador fue de 0,82 y el punto de corte mayor o igual a 23 mostró una sensibilidad de 73,3%. Se encontró: especificidad de 73,6%, valor diagnóstico positivo de 26,6% y valor diagnóstico negativo de 95,5%. El coeficiente de concordancia de Lin fue de 0,75.
Conclusión. La validez y la confiabilidad de la versión en español de la escala en adolescentes en edad escolar del Centro de Estudios Epidemiológicos para la Depresión, fueron similares a las informadas anteriormente, aunque cambió el punto de corte.
Descargas
Los datos de descargas todavía no están disponibles.
Referencias bibliográficas
1. López AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global burden of disease and risk factors. Washington, D.C.: Oxford University Press; 2006.
2. Fergusson DM, Woodward LJ. Mental health, educational, and social role outcomes of adolescents with depression. Arch Gen Psychiatry. 2002;59:225-31.
3. Richardson JL, Radziszewska B, Dent CW, Flay BR. Relationship between after-school care of adolescents and substance use, risk taking, depressed mood, and academic achievement. Pediatrics. 1993;92:32-8.
4. Shrier LA, Harris SK, Beardslee WR. Temporal associations between depressive symptoms and self-reported sexually transmitted disease among adoles-cents. Arch Pediatr Adolesc Med. 2002;156:599-606.
5. Evans E, Hawton K, Rodham K, Deeks J. The prevalence of suicidal phenomena in adolescents: a systematic review of population-based studies. Suicide Life Threat Behav. 2005;35:239-50.
6. Newman DL, Moffitt TE, Caspi A, Magdol L, Silva PA, Stanton WR. Psychiatric disorder in a birth cohort of young adults: prevalence, comorbidity, clinical significance, and new case incidence from ages 11 to 21. J Consult Clin Psychol. 1996;64:552-62.
7. Lewinsohn PM, Rohde P, Seeley JR. Adolescent psychopathology: III. The clinical consequences of comorbidity. J Am Acad Child Adolesc Psychiatry. 1995;34:510-9.
8. Stover E, Fenton W, Rosenfeld A, Insel TR. Depression and comorbid medical illness: the National Institute of Mental Health perspective. Biol Psychiatry. 2003;54:184-6.
9. Fergusson DM, Horwood LJ, Lynskey MT. Prevalence and comorbidity of DSM-III-R diagnoses in a birth cohort of 15-year-olds. J Am Acad Child Adolesc Psychiatry. 1993;32:1127-34.
10. Regier DA, Farmer ME, Rae DS, Myers JK, Kramer M, Robins LN, et al. One-month prevalence of mental disorders in the United States and sociodemographic characteristics: the Epidemiologic Catchment Area study. Acta Psychiatr Scand. 1993;88:35-47.
11. Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: The National Comorbidity Survey. Am J Psychiatry. 1994;151:979-86.
12. Kessler D, Lloyd K, Lewis G, Gray DP. Cross sectional study of symptom attribution and recognition of depression and anxiety in primary care. Br Med J. 1999;318:436-9.
13. Froom J, Schlager DS, Steneker S, Jaffe A. Detection of major depressive disorder in primary care patients. J Am Board Fam Pract. 1993;6:5-11.
14. Wu P, Hoven CW, Bird HR, Moore RE, Cohen P, Alegria M, et al. Depressive and disruptive disorders and mental health service utilization in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1999;38:1081-90
15. Bauer M, Whybrow PC, Angst J, Versiani M, Moller HJ, World Federation of Societies of Biological Psychiatry (WFSBF) Task Force on Treatment Guidelines for Unipolar Depressive Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. World J Biol Psychiatry. 2002;3:69-86.
16. Rao U, Ryan ND, Birmaher B, Dahl RE, Williamson DE, Kaufman J, et al. Unipolar depression in adolescents: Clinical outcome in adulthood. J Am Acad Child Adolesc Psychiatry. 1995;34:566-78.
17. Rey JM, Grayson D, Mojarrad T, Walter G. Changes in the rate of diagnosis of major depression in adolescents following routine use of a depression rating scale. Aus N Z Psychiatry. 2002;36:229-33.
18. McDowell I. Measuring Health. Depression. In: McDowell I, Newell C. A guide to rating scales and questionnaires. Second edition. Washington, D.C.: Oxford University Press; 1996.
19. Wilcox H, Field T, Prodromidis M, Scafidi F. Correlations between the BDI and CES-D in a sample of adolescent mothers. Adolescence. 1998;33:565-74.
20. Radloff L. A self-report depression scale for research in the general population. Applied Psychological Measure. 1977;1:385-401.
21. Campo-Arias A, Díaz-Martínez LA, Rueda-Jaimes GE, Cadena-Afanador LP, Hernández NL. Psychometric properties of CES-D scale among Colombian adults from the general population. Rev Col Psiquiatr. 2007;36:664-74.
22. Obuchowski NA. Sample size calculations in studies of test accuracy. Stat Methods Med Res. 1998;7:371-92.
23. Silva L. Diseño razonado de muestras y captación de datos para la investigación sanitaria. Primera edición. Madrid: Díaz de Santos; 2000.
24. First MB, Spitzer RL, Gibbon M, Williams JB. Entrevista clínica estructurada para los trastornos de eje I del DSM-IV (versión clínica) SCID-I. Barcelona: Masson; 1999.
25. Cronbach LJ. Coefficient alpha and the internal structure of test. Psychometrika. 1951;16:297-334.
26. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating curves: a nonparametric approach. Biometrics. 1988;44:837-45.
27. Beck JR, Shultz EK. The use of relative operating characteristics (ROC) curves in test performance evaluation. Arch Lab Pathol Med. 1986;110:13-20.
28. Kraemer H. Sensitivity and specificity: The signal detection approach. Evaluating medical tests: Objective and quantitative guidelines. First edition. California: Sage Publications; 1992.
29. Lin LI-K. A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989;45:255-68.
30. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-10.
31. Bradley EL, Blackwood LG. Comparing paired data: a simultaneous test for means and variances. American Statistician. 1989;43:234-5.
32. StataCorp. Stata statistic software: release 9.0. College Station, TX: StataCorp LP; 2005.
33. Irwing L, Bossuyt P, Glasziou P, Lijmer J. Designing studies to ensure that estimates of test accuracy are transferable. BMJ. 2002;324:669-71.
34. Radloff LS, Locke BZ. The Community Mental Health Assessment Survey and the CES-D scale. En: Weissman M, Myers J, Ross C, editors. Community surveys. New Brunswick, NJ: Rutgers University Press; 1986.
35. Schoenbach VJ, Kaplan BH, Grimson RC, Wagner EH. Use of a symptom scale to study the prevalence of a depressive syndrome in young adolescents. Am J Epidemiol. 1982;116:791-800.
36. Radloff LS. The use of the Center for Epidemiologic Studies Depression scale in adolescents and young adults. J Youth Adolesc. 1991;20:149-66.
37. Roberts RE, Andrews JA, Lewinsohn PM, Hops H. Assessment of depression in adolescents using the Center for Epidemiologic Studies Depression Scale. Psychol Assessment. 1990;2:122-8.
38. Rushton JL, Forcier M, Schectman RM. Epidemiology of depressive symptoms in the National Longitudinal Study of Adolescent Health. J Am Acad Child Adolesc Psychiatry. 2002;41:199-205.
39. Schoenbach VJ, Kaplan BH, Grimson RC, Wagner EH. Use of a symptom scale to study the prevalence of a depressive syndrome in young adolescents. Am J Epidemiol. 1982; 116:791-800.
40. Fava GA. Assessing depressive symptoms across cultures: Italian validation of the CES-D self-rating scale. J Clin Psychol. 1983;39:249-51.
41. Roberts RE, Lewinsohn PM, Seeley JR. Screening for adolescent depression: A comparison of depression scales. J Am Acad Child Adolesc Psychiatry. 1991;30:58-66.
42. Beekman AT, Deeg DJ, van Limbeek J, Braam AW, De Vries MZ, van Tilburg W. Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in The Netherlands. Psychol Med. 1997;27:231-5.
43. Boyd JH, Weissman MM, Thompson D, Myers JK. Screening for depression in a community sample. Arch Gen Psychiatry. 1982;39:195-9.
44. Breslau N. Depressive symptoms, major depression, and generalized anxiety: a comparison of self-reports on CES-D and results from diagnostic interviews. Psychiatry Res. 1985;15:219-29.
2. Fergusson DM, Woodward LJ. Mental health, educational, and social role outcomes of adolescents with depression. Arch Gen Psychiatry. 2002;59:225-31.
3. Richardson JL, Radziszewska B, Dent CW, Flay BR. Relationship between after-school care of adolescents and substance use, risk taking, depressed mood, and academic achievement. Pediatrics. 1993;92:32-8.
4. Shrier LA, Harris SK, Beardslee WR. Temporal associations between depressive symptoms and self-reported sexually transmitted disease among adoles-cents. Arch Pediatr Adolesc Med. 2002;156:599-606.
5. Evans E, Hawton K, Rodham K, Deeks J. The prevalence of suicidal phenomena in adolescents: a systematic review of population-based studies. Suicide Life Threat Behav. 2005;35:239-50.
6. Newman DL, Moffitt TE, Caspi A, Magdol L, Silva PA, Stanton WR. Psychiatric disorder in a birth cohort of young adults: prevalence, comorbidity, clinical significance, and new case incidence from ages 11 to 21. J Consult Clin Psychol. 1996;64:552-62.
7. Lewinsohn PM, Rohde P, Seeley JR. Adolescent psychopathology: III. The clinical consequences of comorbidity. J Am Acad Child Adolesc Psychiatry. 1995;34:510-9.
8. Stover E, Fenton W, Rosenfeld A, Insel TR. Depression and comorbid medical illness: the National Institute of Mental Health perspective. Biol Psychiatry. 2003;54:184-6.
9. Fergusson DM, Horwood LJ, Lynskey MT. Prevalence and comorbidity of DSM-III-R diagnoses in a birth cohort of 15-year-olds. J Am Acad Child Adolesc Psychiatry. 1993;32:1127-34.
10. Regier DA, Farmer ME, Rae DS, Myers JK, Kramer M, Robins LN, et al. One-month prevalence of mental disorders in the United States and sociodemographic characteristics: the Epidemiologic Catchment Area study. Acta Psychiatr Scand. 1993;88:35-47.
11. Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: The National Comorbidity Survey. Am J Psychiatry. 1994;151:979-86.
12. Kessler D, Lloyd K, Lewis G, Gray DP. Cross sectional study of symptom attribution and recognition of depression and anxiety in primary care. Br Med J. 1999;318:436-9.
13. Froom J, Schlager DS, Steneker S, Jaffe A. Detection of major depressive disorder in primary care patients. J Am Board Fam Pract. 1993;6:5-11.
14. Wu P, Hoven CW, Bird HR, Moore RE, Cohen P, Alegria M, et al. Depressive and disruptive disorders and mental health service utilization in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1999;38:1081-90
15. Bauer M, Whybrow PC, Angst J, Versiani M, Moller HJ, World Federation of Societies of Biological Psychiatry (WFSBF) Task Force on Treatment Guidelines for Unipolar Depressive Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. World J Biol Psychiatry. 2002;3:69-86.
16. Rao U, Ryan ND, Birmaher B, Dahl RE, Williamson DE, Kaufman J, et al. Unipolar depression in adolescents: Clinical outcome in adulthood. J Am Acad Child Adolesc Psychiatry. 1995;34:566-78.
17. Rey JM, Grayson D, Mojarrad T, Walter G. Changes in the rate of diagnosis of major depression in adolescents following routine use of a depression rating scale. Aus N Z Psychiatry. 2002;36:229-33.
18. McDowell I. Measuring Health. Depression. In: McDowell I, Newell C. A guide to rating scales and questionnaires. Second edition. Washington, D.C.: Oxford University Press; 1996.
19. Wilcox H, Field T, Prodromidis M, Scafidi F. Correlations between the BDI and CES-D in a sample of adolescent mothers. Adolescence. 1998;33:565-74.
20. Radloff L. A self-report depression scale for research in the general population. Applied Psychological Measure. 1977;1:385-401.
21. Campo-Arias A, Díaz-Martínez LA, Rueda-Jaimes GE, Cadena-Afanador LP, Hernández NL. Psychometric properties of CES-D scale among Colombian adults from the general population. Rev Col Psiquiatr. 2007;36:664-74.
22. Obuchowski NA. Sample size calculations in studies of test accuracy. Stat Methods Med Res. 1998;7:371-92.
23. Silva L. Diseño razonado de muestras y captación de datos para la investigación sanitaria. Primera edición. Madrid: Díaz de Santos; 2000.
24. First MB, Spitzer RL, Gibbon M, Williams JB. Entrevista clínica estructurada para los trastornos de eje I del DSM-IV (versión clínica) SCID-I. Barcelona: Masson; 1999.
25. Cronbach LJ. Coefficient alpha and the internal structure of test. Psychometrika. 1951;16:297-334.
26. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating curves: a nonparametric approach. Biometrics. 1988;44:837-45.
27. Beck JR, Shultz EK. The use of relative operating characteristics (ROC) curves in test performance evaluation. Arch Lab Pathol Med. 1986;110:13-20.
28. Kraemer H. Sensitivity and specificity: The signal detection approach. Evaluating medical tests: Objective and quantitative guidelines. First edition. California: Sage Publications; 1992.
29. Lin LI-K. A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989;45:255-68.
30. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-10.
31. Bradley EL, Blackwood LG. Comparing paired data: a simultaneous test for means and variances. American Statistician. 1989;43:234-5.
32. StataCorp. Stata statistic software: release 9.0. College Station, TX: StataCorp LP; 2005.
33. Irwing L, Bossuyt P, Glasziou P, Lijmer J. Designing studies to ensure that estimates of test accuracy are transferable. BMJ. 2002;324:669-71.
34. Radloff LS, Locke BZ. The Community Mental Health Assessment Survey and the CES-D scale. En: Weissman M, Myers J, Ross C, editors. Community surveys. New Brunswick, NJ: Rutgers University Press; 1986.
35. Schoenbach VJ, Kaplan BH, Grimson RC, Wagner EH. Use of a symptom scale to study the prevalence of a depressive syndrome in young adolescents. Am J Epidemiol. 1982;116:791-800.
36. Radloff LS. The use of the Center for Epidemiologic Studies Depression scale in adolescents and young adults. J Youth Adolesc. 1991;20:149-66.
37. Roberts RE, Andrews JA, Lewinsohn PM, Hops H. Assessment of depression in adolescents using the Center for Epidemiologic Studies Depression Scale. Psychol Assessment. 1990;2:122-8.
38. Rushton JL, Forcier M, Schectman RM. Epidemiology of depressive symptoms in the National Longitudinal Study of Adolescent Health. J Am Acad Child Adolesc Psychiatry. 2002;41:199-205.
39. Schoenbach VJ, Kaplan BH, Grimson RC, Wagner EH. Use of a symptom scale to study the prevalence of a depressive syndrome in young adolescents. Am J Epidemiol. 1982; 116:791-800.
40. Fava GA. Assessing depressive symptoms across cultures: Italian validation of the CES-D self-rating scale. J Clin Psychol. 1983;39:249-51.
41. Roberts RE, Lewinsohn PM, Seeley JR. Screening for adolescent depression: A comparison of depression scales. J Am Acad Child Adolesc Psychiatry. 1991;30:58-66.
42. Beekman AT, Deeg DJ, van Limbeek J, Braam AW, De Vries MZ, van Tilburg W. Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in The Netherlands. Psychol Med. 1997;27:231-5.
43. Boyd JH, Weissman MM, Thompson D, Myers JK. Screening for depression in a community sample. Arch Gen Psychiatry. 1982;39:195-9.
44. Breslau N. Depressive symptoms, major depression, and generalized anxiety: a comparison of self-reports on CES-D and results from diagnostic interviews. Psychiatry Res. 1985;15:219-29.
Cómo citar
1.
Rueda-Jaimes GE, Camacho PA, Latorre JF, Navarro-Mancilla Álvaro A, Escobar M, Franco JA. Validez y confiabilidad de la escala del Center for Epidemiologic Studies-Depression en estudiantes adolescentes de Colombia. Biomed. [Internet]. 18 de diciembre de 2009 [citado 4 de abril de 2025];29(2):260-9. Disponible en: https://revistabiomedicaorg.biteca.online/index.php/biomedica/article/view/28
Algunos artículos similares:
- Oscar F. Herrán, María F. Ardila, Validez interna y reproducibilidad de la prueba CAGE en Bucaramanga, Colombia. , Biomédica: Vol. 25 Núm. 2 (2005)
- German Eduardo Rueda, Luis Alfonso Díaz, Adalberto Campo, Jaider Alfonso Barros, Gissel Constanza Avila, Lutzi Tathiana Oróstegui, Betty Cecilia Osorio, Laura del Pilar Cadena, Validación de la encuesta SCOFF para tamizaje de trastornos de la conducta alimentaria en mujeres universitarias. , Biomédica: Vol. 25 Núm. 2 (2005)
- Nelsy Loango, Martha Lucía Gallego, Beatriz Restrepo, Patricia Landázuri, Diferencias de sexo, edad y lípidos plasmáticos asociadas al polimorfismo de la apolipoproteína E en un grupo de escolares de Quindío, Colombia , Biomédica: Vol. 29 Núm. 3 (2009)
- Elpidia Poveda, Ney E. Callas, César M. Baracaldo, Carlina Castillo, Patricia Hernández, Concentración sérica de leptina en población escolar de cinco departamentos del centro-oriente colombiano y su relación con parámetros antropométricos y perfil lipídico , Biomédica: Vol. 27 Núm. 4 (2007)
- Ney Callas, Elpidia Poveda, César Baracaldo, Patricia Hernández, Carlina Castillo, Martha Guerra, Polimorfismo genético de la apolipoproteína E en un grupo de escolares del centro-oriente colombiano: comparación con las concentraciones plasmáticas de lípidos y apolipoproteínas , Biomédica: Vol. 27 Núm. 4 (2007)
- Elpidia Poveda, Ney Callas, César Baracaldo, Carlina Castillo, Patricia Hernández, Martha Guerra, Evaluación de las concentraciones de lípidos y apoproteínas A-I y B-100 en un grupo de escolares de cinco departamentos del centro-oriente de Colombia , Biomédica: Vol. 27 Núm. 3 (2007)
- Constanza Pardo, Marion Piñeros, Consumo de tabaco en cinco ciudades de Colombia, Encuesta Mundial de Tabaquismo en Jóvenes, 2007 , Biomédica: Vol. 30 Núm. 4 (2010)
- Ana Cecilia Aguilar, Alberto Pradilla, Mildrey Mosquera, Ana Beatriz Gracia, José Guillermo Ortega, Jaime Humberto Leiva, Robinson Ramírez-Vélez, Percentiles de condición física de niños y adolescentes de Santiago de Cali, Colombia , Biomédica: Vol. 31 Núm. 2 (2011)
- Nathalia Cortés-Marín , Luis Miguel Sosa-Ávila , Andrés Felipe Arias, Leonardo David Escobar-Cortés, Juan Pablo Rojas-Hernández , Recomendaciones sobre vacunación en niños y adolescentes con errores innatos de la inmunidad según el programa ampliado de inmunización colombiano , Biomédica: Vol. 44 Núm. Sp. 2 (2024): Inmunología clínica
- Claudia Lucía Colorado, Guillermo Sánchez, Martha Inírida Guerrero, Clara Inés León, Confiabilidad y concordancia de dos escalas de lectura de baciloscopias para clasificación y seguimiento del tratamiento con múltiples medicamentos de los pacientes con lepra , Biomédica: Vol. 31 Núm. 3 (2011)
Publicado
2009-12-18
Número
Sección
Artículos originales
| Estadísticas de artículo | |
|---|---|
| Vistas de resúmenes | |
| Vistas de PDF | |
| Descargas de PDF | |
| Vistas de HTML | |
| Otras vistas | |
